SCHEMBL25187893

SCHEMBL25187893

CC(C)(C)c1ccc(Nc2ccc(C=O)cc2)cc1F

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 2/20 0.46
▸ CFTR P13569 1/20 0.37
▸ SOS1 Q07889 2/20 0.36
▸ CYP2A6 P11509 1/20 0.33
▸ PTGS1 P23219 1/20 0.33
▸ PTGS2 P35354 1/20 0.33
▸ DHODH Q02127 1/20 0.33
▸ GAA P10253 1/20 0.32
▸ EPHX2 P34913 1/20 0.32
▸ NR1H4 Q96RI1 1/20 0.32
▸ RAPGEF4 Q8WZA2 1/20 0.32
▸ FGFR2 P21802 1/20 0.32
▸ AKR1C3 P42330 1/20 0.32
▸ AKR1C2 P52895 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ TYR P14679 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16846737 0.81 KIF11 (0.51) KIF11CYP2A6PTGS1PTGS2ALDH1A1
SCHEMBL30874807 0.81 KIF11 (0.51) KIF11CYP2A6PTGS1PTGS2ALDH1A1
SCHEMBL25194892 0.81 HTT (0.44) CFTRSOS1PTGS1PTGS2DHODH
SCHEMBL26154818 0.74 EPHX2 (0.51) KIF11CYP2A6GAAEPHX2NR1H4
SCHEMBL7554959 0.73 CYP2A6 (0.50) CYP2A6PTGS1PTGS2GAAALDH1A1
SCHEMBL25204894 0.73 CFTR (0.36) KIF11CFTRSOS1DHODHGAA
SCHEMBL13528298 0.72 CFTR (0.40) KIF11CFTRDHODHNR1H4RAPGEF4
SCHEMBL17487923 0.72 PTGS1 (0.44) CYP2A6PTGS1ALDH1A1
SCHEMBL25196222 0.71 CYP2A6 (0.41) CYP2A6GAAEPHX2NR1H4ALDH1A1
SCHEMBL13496965 0.71 PTGS2 (0.43) KIF11CYP2A6PTGS1PTGS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151252-B Iron death inhibitor-diarylamine acetamides 维泰瑞隆有限公司 2024-08-27 — — CN disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
CN-115151252-A Iron death inhibitors diarylamine para-acetamides 维泰瑞隆有限公司 2022-10-04 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES AIFM2, FECH, GPX4 KIF11 3762/4885CFTR 2526/4885SOS1 1466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback